Jonathan Cramer

647 total citations
25 papers, 479 citations indexed

About

Jonathan Cramer is a scholar working on Molecular Biology, Organic Chemistry and Immunology. According to data from OpenAlex, Jonathan Cramer has authored 25 papers receiving a total of 479 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 8 papers in Organic Chemistry and 7 papers in Immunology. Recurrent topics in Jonathan Cramer's work include Glycosylation and Glycoproteins Research (5 papers), Protein Structure and Dynamics (5 papers) and Chemical Synthesis and Analysis (4 papers). Jonathan Cramer is often cited by papers focused on Glycosylation and Glycoproteins Research (5 papers), Protein Structure and Dynamics (5 papers) and Chemical Synthesis and Analysis (4 papers). Jonathan Cramer collaborates with scholars based in Germany, Switzerland and India. Jonathan Cramer's co-authors include Beat Ernst, Christoph P. Sager, G. Klebe, A. Heine, S.G. Krimmer, Robert Karlsson, Said Rabbani, Siegfried Hünig, Michael Betz and Xiaohua Jiang and has published in prestigious journals such as Journal of the American Chemical Society, Angewandte Chemie International Edition and Journal of Medicinal Chemistry.

In The Last Decade

Jonathan Cramer

24 papers receiving 469 citations

Peers

Countries citing papers authored by Jonathan Cramer

Since Specialization

Citations

This map shows the geographic impact of Jonathan Cramer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonathan Cramer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonathan Cramer more than expected).

Fields of papers citing papers by Jonathan Cramer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jonathan Cramer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonathan Cramer. The network helps show where Jonathan Cramer may publish in the future.

Co-authorship network of co-authors of Jonathan Cramer

This figure shows the co-authorship network connecting the top 25 collaborators of Jonathan Cramer. A scholar is included among the top collaborators of Jonathan Cramer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jonathan Cramer. Jonathan Cramer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Human chitinases and chitinase-like proteins as emerging drug targets – a medicinal chemistry perspective 2025 ·RSC Medicinal Chemistry ·(unknown), (unknown), Holger Gohlke, Jonathan Cramer	1
2	Analogues of the pan-selectin antagonist rivipansel (GMI-1070) 2024 ·European Journal of Medicinal Chemistry ·(unknown), Martin Smieško, Roman P. Jakob, Tobias Mühlethaler, Jonathan Cramer, (unknown), Said Rabbani, Oliver Schwardt, Beat Ernst	4
3	Does size matter? – Comparing pyranoses with septanoses as ligands of the bacterial lectin FimH 2024 ·European Journal of Medicinal Chemistry ·Jonathan Cramer, (unknown), Xiaohua Jiang, (unknown), Marleen Silbermann, Said Rabbani, (unknown), (unknown), Beat Ernst, Mark W. Peczuh	1
4	Thermodynamics-Guided Design Reveals a Cooperative Hydrogen Bond in DC-SIGN-targeted Glycomimetics 2024 ·Journal of Medicinal Chemistry ·(unknown), Xiaohua Jiang, Roman P. Jakob, (unknown), Oliver Schwardt, Said Rabbani, Timm Maier, Beat Ernst, Jonathan Cramer	2
5	The role of glycosylation patterns of viral glycoproteins and cell entry receptors in arenavirus infection. 2023 ·Biomedicine & Pharmacotherapy ·Michał Gorzkiewicz, Jonathan Cramer, Haifeng C. Xu, Philipp A. Lang	7
6	Combating DC‐SIGN‐mediated SARS‐CoV‐2 dissemination by glycan‐mimicking polymers 2023 ·Archiv der Pharmazie ·Jonathan Cramer, Xiaohua Jiang, (unknown), Beat Ernst	0
7	Sialic Acid Derivatives Inhibit SiaT Transporters and Delay Bacterial Growth 2022 ·ACS Chemical Biology ·(unknown), Mariafrancesca Scalise, Christer Larsson, (unknown), (unknown), (unknown), Jonathan Cramer, Weixiao Yuan Wahlgren, (unknown), Richard Johnsson, Oliver Schwardt, Beat Ernst, Rosmarie Friemann, Renwick C. J. Dobson, Cesare Indiveri, Jenny Schelin, Ulf J. Nilsson, Ulf Ellervik	6
8	Poly‐ l‐ lysine Glycoconjugates Inhibit DC‐SIGN‐mediated Attachment of Pandemic Viruses 2021 ·ChemMedChem ·Jonathan Cramer, (unknown), Xiaohua Jiang, Timothy Sharpe, Lijuan Pang, (unknown), Said Rabbani, Beat Ernst	16
9	Prediction and Validation of a Druggable Site on Virulence Factor of Drug Resistant Burkholderia cenocepacia ** 2021 ·Chemistry - A European Journal ·(unknown), (unknown), Jonathan Cramer, Francesca Vasile, Beat Ernst, Anne Imberty, Anna Bernardi, Annabelle Varrot, Laura Belvisi	8
10	Sweet Drugs for Bad Bugs: A Glycomimetic Strategy against the DC-SIGN-Mediated Dissemination of SARS-CoV-2 2021 ·Journal of the American Chemical Society ·Jonathan Cramer, (unknown), (unknown), Roman P. Jakob, (unknown), (unknown), Xiaohua Jiang, Said Rabbani, Oliver Schwardt, Gert Zimmer, (unknown), (unknown), Timm Maier, Beat Ernst	37
11	Medicinal chemistry of the myeloid C-type lectin receptors Mincle, Langerin, and DC-SIGN 2021 ·RSC Medicinal Chemistry ·Jonathan Cramer	18
12	Enhancing the enthalpic contribution of hydrogen bonds by solvent shielding 2020 ·RSC Chemical Biology ·Jonathan Cramer, Xiaohua Jiang, (unknown), Marleen Silbermann, (unknown), (unknown), (unknown), Roman P. Jakob, Said Rabbani, Timm Maier, Beat Ernst	12
13	A Potent Mimetic of the Siglec‐8 Ligand 6’‐Sulfo‐Sialyl Lewis^x 2020 ·ChemMedChem ·(unknown), Gabriele Conti, (unknown), Jonathan Cramer, Xiaohua Jiang, Said Rabbani, (unknown), (unknown), (unknown), Daniel Ricklin, Oliver Schwardt, Beat Ernst	12
14	Improvement of Aglycone π‐Stacking Yields Nanomolar to Sub‐nanomolar FimH Antagonists 2019 ·ChemMedChem ·(unknown), Jonathan Cramer, Tobias Mühlethaler, (unknown), Marleen Silbermann, Said Rabbani, (unknown), (unknown), Roman P. Jakob, Christoph P. Sager, Martin Smieško, Oliver Schwardt, Timm Maier, Beat Ernst	28
15	How Nothing Boosts Affinity: Hydrophobic Ligand Binding to the Virtually Vacated S₁′ Pocket of Thermolysin 2017 ·Journal of the American Chemical Society ·S.G. Krimmer, Jonathan Cramer, J. Schiebel, A. Heine, G. Klebe	21
16	A False‐Positive Screening Hit in Fragment‐Based Lead Discovery: Watch out for the Red Herring 2017 ·Angewandte Chemie International Edition ·Jonathan Cramer, J. Schiebel, Tobias Wulsdorf, Kristof Grohe, Eszter E. Najbauer, (unknown), Nedyalka Radeva, (unknown), Uwe Linne, Rasmus Linser, A. Heine, G. Klebe	11
17	Paying the Price of Desolvation in Solvent-Exposed Protein Pockets: Impact of Distal Solubilizing Groups on Affinity and Binding Thermodynamics in a Series of Thermolysin Inhibitors 2017 ·Journal of Medicinal Chemistry ·Jonathan Cramer, S.G. Krimmer, A. Heine, G. Klebe	34
18	Elucidating the Origin of Long Residence Time Binding for Inhibitors of the Metalloprotease Thermolysin 2016 ·ACS Chemical Biology ·Jonathan Cramer, S.G. Krimmer, (unknown), Tobias Wulsdorf, Robert Karlsson, A. Heine, G. Klebe	14
19	Ungewöhnliche Bildung des ungewöhnlichen 1,2,8,9‐Tetraaza‐1,8‐cyclotetradecadien‐3,10‐diol‐Systems und seines 5,12‐Dioxaanalogen 1968 ·Angewandte Chemie ·Siegfried Hünig, Jonathan Cramer	9
20	Unusual Formation of the Unusual 1,2,8,9‐Tetraaza‐1,8‐cyclotetradecadiene‐3,10‐diol System and its 5,12‐Dioxa Analog 1968 ·Angewandte Chemie International Edition in English ·Siegfried Hünig, Jonathan Cramer	7

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact